share_log

Illumina | 4: Statement of changes in beneficial ownership of securities-Director MACMILLAN STEPHEN P

SEC announcement ·  May 17 18:13
Summary by Moomoo AI
Stephen P. MacMillan, associated with Illumina, Inc. [ILMN], completed a stock transaction on May 16, 2024, involving the grant of 2,622 shares of common stock at no cost. Following this transaction, MacMillan's direct holdings in the company increased to a total of 4,129 shares. The transaction, which was classified as a grant, award, or other acquisition, was executed under the transaction code 'A'. This event reflects a notable increase in MacMillan's stake in the biotechnology firm, which specializes in sequencing and array-based solutions for genetic analysis.
Stephen P. MacMillan, associated with Illumina, Inc. [ILMN], completed a stock transaction on May 16, 2024, involving the grant of 2,622 shares of common stock at no cost. Following this transaction, MacMillan's direct holdings in the company increased to a total of 4,129 shares. The transaction, which was classified as a grant, award, or other acquisition, was executed under the transaction code 'A'. This event reflects a notable increase in MacMillan's stake in the biotechnology firm, which specializes in sequencing and array-based solutions for genetic analysis.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more